Loading color scheme

Ecosystem Startup


Rise Therapeutics is developing microbiome-based, functionally-directed oral immunotherapies to treat a wide range of human diseases. Leveraging a proprietary oral biologics delivery platform and internal clinical GMP manufacturing capabilities, Rise and its pipeline development partners can rapidly complete preclinical/IND-studies and progress into early-stage clinical development.

Innovation Space:
Microbiome, Inflammation, Autoimmunity, Oncology

Latest News